T1	Participants 624 721	179 children (93 male, 86 female; age 6-18 years) received zonisamide (mean duration 370.6 days).
T2	Participants 415 523	children with partial epilepsy received adjunctive zonisamide (target dose 8 mg/kg/day; maximum 500 mg/day).
